| Date Filed | Type | Description |
| 05/26/2023 |
SC 13D/A
| TAKEDA PHARMACEUTICAL CO LTD reports a 0% stake in Calithera Biosciences, Inc. |
| 02/07/2023 |
SC 13G/A
| BlackRock Inc. reports a 7.2% stake in TAKEDA PHARMACEUTICAL COMPANY LIMITED |
| 02/03/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/03/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/03/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/03/2023 |
SC 13G/A
| Sumitomo Mitsui Trust Holdings, Inc. reports a 5.9% stake in Takeda Pharmaceutical Company Limited |
| 08/04/2022 |
SC 13G/A
| TAKEDA PHARMACEUTICAL CO LTD reports a 5% stake in Exit Filing)* BIOMX INC. |
| 07/06/2022 |
SC 13D/A
| TAKEDA PHARMACEUTICAL CO LTD reports a 15% stake in Calithera Biosciences, Inc. |
| 05/09/2022 |
SC 13D
| TAKEDA PHARMACEUTICAL CO LTD reports a 17.1% stake in HilleVax, Inc. |
| 04/21/2022 |
SC 13D
| TAKEDA PHARMACEUTICAL CO LTD reports a 13.2% stake in Calithera Biosciences, Inc. |
| 02/04/2022 |
SC 13G/A
| Sumitomo Mitsui Trust Holdings, Inc. reports a 5.7% stake in Takeda Pharmaceutical Company Limited |
| 02/02/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/14/2022 |
SC 13G
| TAKEDA PHARMACEUTICAL CO LTD reports a 5.4% stake in Xilio Therapeutics, Inc. |
| 01/14/2022 |
SC 13G/A
| TAKEDA PHARMACEUTICAL CO LTD reports a 5% stake in SHATTUCK LABS, INC. |
| 01/14/2022 |
SC 13G
| TAKEDA PHARMACEUTICAL CO LTD reports a 9.7% stake in DAY ONE BIOPHARMACEUTICALS, INC. |
| 10/25/2021 |
SC 13G/A
| TAKEDA PHARMACEUTICAL CO LTD reports a 1.7% stake in MIRUM PHARMACEUTICALS, INC. |
| 10/18/2021 |
SC 13G/A
| TAKEDA PHARMACEUTICAL CO LTD reports a 5.2% stake in BIOMX INC. |
| 09/14/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/30/2021 |
SC 13G/A
| TAKEDA PHARMACEUTICAL CO LTD reports a 1.1% stake in HOOKIPA PHARMA INC. |
| 04/06/2021 |
SC 13D/A
| TAKEDA PHARMACEUTICAL CO LTD reports a 22.3% stake in Phathom Pharmaceuticals, Inc. |
| 04/01/2021 |
SC 13D/A
| TAKEDA PHARMACEUTICAL CO LTD reports a 22.3% stake in Phathom Pharmaceuticals, Inc. |
| 02/05/2021 |
SC 13G
| Sumitomo Mitsui Trust Holdings, Inc. reports a 6% stake in Takeda Pharmaceutical Company Limited |
| 02/01/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/29/2021 |
SC 13G/A
| TAKEDA PHARMACEUTICAL CO LTD reports a 5.1% stake in SHATTUCK LABS, INC. |
| 01/27/2021 |
SC 13G/A
| TAKEDA PHARMACEUTICAL CO LTD reports a 7.2% stake in MIRUM PHARMACEUTICALS, INC. |
| 01/25/2021 |
SC 13G/A
| TAKEDA PHARMACEUTICAL CO LTD reports a 0% stake in Translate Bio, Inc. |
| 02/14/2020 |
SC 13G/A
| CAUSEWAY CAPITAL MANAGEMENT LLC reports a 2.6% stake in TAKEDA PHARMACEUTICAL CO LTD |
| 02/06/2020 |
SC 13G/A
| BlackRock Inc. reports a 6.4% stake in TAKEDA PHARMACEUTICAL COMPANY LIMITED |
| 01/27/2020 |
SC 13D/A
| TAKEDA PHARMACEUTICAL CO LTD reports a 27% stake in Phathom Pharmaceuticals, Inc. |
| 01/24/2020 |
SC 13G/A
| TAKEDA PHARMACEUTICAL CO LTD reports a 4.4% stake in MYOVANT SCIENCES LTD. |
| 01/24/2020 |
SC 13G/A
| TAKEDA PHARMACEUTICAL CO LTD reports a 10.8% stake in MYOVANT SCIENCES LTD. |
| 11/22/2019 |
SC 13G/A
| TAKEDA PHARMACEUTICAL CO LTD reports a 15.8% stake in OVID THERAPUETICS INC. |
| 11/22/2019 |
SC 13G/A
| TAKEDA PHARMACEUTICAL CO LTD reports a 11.6% stake in OVID THERAPUETICS INC. |
| 11/06/2019 |
SC 13D
| TAKEDA PHARMACEUTICAL CO LTD reports a 24.7% stake in Phathom Pharmaceuticals, Inc. |
|